Xanthus Pharmaceuticals' Acquisition

Xanthus Pharmaceuticals was acquired by Sarossa Capital on June 09, 2008.

Xanthus Pharmaceuticals, Inc. is developing a portfolio of novel, clinical-stage, small-molecule therapeutic candidates through a management team whose accomplished track record encompasses all aspect…

Articles about Xanthus Pharmaceuticals' Acquisition: